CIENCIAS FARMACÉUTICAS
Fachbereich
Hospital Universitario 12 de Octubre
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (10)
2023
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
-
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
2019
-
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
Annals of Oncology, Vol. 30, Núm. 4, pp. 612-620
2007
-
Sucesos adversos en cirugía general y de aparato digestivo en los hospitales españoles
Cirugia Espanola, Vol. 82, Núm. 5, pp. 268-277
-
Un aspecto crítico de la calidad: Los sucesos adversos en los hospitales españoles: Resultados del estudio eneas
Medicina Preventiva, Vol. 13, Núm. SPEC. ISS., pp. 64-70
2001
-
Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy
Clinical Pharmacokinetics, Vol. 40, Núm. 1, pp. 63-71
1998
-
Influence of diagnostic and treatment factors in the population pharmacokinetics of gentamicin
Journal of Clinical Pharmacy and Therapeutics, Vol. 23, Núm. 2, pp. 141-148